Organon & Co. Files 8-K with Corporate Updates

Ticker: OGN · Form: 8-K · Filed: May 27, 2025 · CIK: 1821825

Organon & CO. 8-K Filing Summary
FieldDetail
CompanyOrganon & CO. (OGN)
Form Type8-K
Filed DateMay 27, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, financial-statements

TL;DR

Organon & Co. filed an 8-K on 5/27/25 with corporate details and financial statements.

AI Summary

Organon & Co. filed an 8-K on May 27, 2025, to report other events and financial statements. The filing details the company's corporate information, including its address at 30 Hudson Street, Floor 33, Jersey City, NJ, and its phone number (551) 430-6900. Organon & Co. is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.

Why It Matters

This filing provides essential corporate and financial information for Organon & Co., which is crucial for investors and stakeholders to stay informed about the company's structure and reporting status.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain information that inherently increases risk.

Key Players & Entities

FAQ

What is the primary purpose of this Form 8-K filing for Organon & Co.?

The Form 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of May 27, 2025.

When was the earliest event reported in this filing?

The earliest event reported was on May 27, 2025.

What is Organon & Co.'s principal executive office address?

Organon & Co.'s principal executive offices are located at 30 Hudson Street, Floor 33, Jersey City, NJ 07302.

What is the SEC file number for Organon & Co.?

The SEC file number for Organon & Co. is 001-40235.

In which state is Organon & Co. incorporated?

Organon & Co. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 27, 2025 regarding Organon & Co. (OGN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing